BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Non-GAAP Adjusted Selling, General & Administrative by Year
Non-GAAP Adjusted Selling, General & Administrative Expense ($M) ($M)
BeOne Medicines Non-GAAP Adjusted Selling, General & Administrative: $1,743M in FY2025, up 12.5% from a year earlier.
Where the FY2025 figure comes from
“|| Adjusted selling, general and administrative | $ | 471,468 | $ | 433,059 | $ | 1,743,118 | $ | 1,549,864”
Source: Form 8-K (filed 2026-02-26) ↗
Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Selling, General & Administrative Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,743 | +12.5% | Form 8-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 1,550 | +20.6% | Form 8-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 1,285 | +19.2% | Form 8-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 1,078 | – | Form 8-K (filed 2024-02-26) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Adjusted Selling, General & Administrative ($M), annual FY2022–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-sga-exp
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.